Axa
KRTX

Axa’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Axa’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,415
Closed -$5.99M – 1152
2023
Q3 		$5.99M Sell
35,415
-126
-0.4% -$23.7K 0.02% 497
2023
Q2 		$7.71M Buy
35,541
+16,913
+91% +$3.62M 0.03% 460
2023
Q1 		$3.38M Sell
18,628
-22,537
-55% -$4.31M 0.01% 657
2022
Q4 		$8.09M Sell
41,165
-222
-0.5% -$47.6K 0.03% 482
2022
Q3 		$9.31M Sell
41,387
-6,344
-13% -$1.28M 0.04% 451
2022
Q2 		$6.04M Sell
47,731
-929
-2% -$107K 0.02% 532
2022
Q1 		$6.17M Sell
48,660
-25,811
-35% -$2.91M 0.02% 589
2021
Q4 		$9.76M Buy
74,471
+889
+1% +$115K 0.02% 499
2021
Q3 		$9M Buy
73,582
+2,709
+4% +$313K 0.03% 528
2021
Q2 		$8.08M Sell
70,873
-102
-0.1% -$11.9K 0.02% 576
2021
Q1 		$8.53M Buy
70,975
+18,166
+34% +$2.06M 0.03% 552
2020
Q4 		$5.37M Buy
52,809
+2,126
+4% +$197K 0.02% 676
2020
Q3 		$3.92M Sell
50,683
-363
-0.7% -$30.9K 0.01% 687
2020
Q2 		$5.69M Buy
+51,046
New +$4.44M 0.02% 579

Other funds holding KRTX

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Axa's KRTX Position: Q4 2023 in Review

Axa sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 35,415 shares — an estimated $5.99M sold.

Axa first reported a position in KRTX in Q2 2020 and held it in 14 quarters. The position peaked at $9.76M in Q4 2021. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Axa reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Axa sold 35,415 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $5.99M.
  • Axa first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Axa's Karuna Therapeutics, Inc. Common Stock position peaked at $9.76M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.